Frazier Life Sciences Management, L.P. Q1 2022 Filing
Filed May 16, 2022
Portfolio Value
$1.2T
Holdings
42
Report Date
Q1 2022
Filing Type
13F-HR
All Holdings (42 positions)
| # | Stock | Shares | Value | % Portfolio | Type |
|---|---|---|---|---|---|
| 1 | ARQTARCUTIS BIOTHERAPEUTICS INC | 8,434,232 | $162.4B | 13.84% | |
| 2 | PHATPHATHOM PHARMACEUTICALS INC | 5,827,415 | $79.3B | 6.76% | |
| 3 | MIRMMIRUM PHARMACEUTICALS INC | 3,566,912 | $78.5B | 6.69% | |
| 4 | —SIERRA ONCOLOGY INC | 2,342,198 | $75.1B | 6.40% | |
| 5 | KRYSKRYSTAL BIOTECH INC | 866,250 | $57.6B | 4.91% | |
| 6 | —IMAGO BIOSCIENCES INC | 2,971,274 | $57.3B | 4.88% | |
| 7 | PCVXVAXCYTE INC | 2,309,554 | $55.8B | 4.75% | |
| 8 | SNDXSYNDAX PHARMACEUTICALS INC | 3,195,403 | $55.5B | 4.73% | |
| 9 | 290ACHINOOK THERAPEUTICS INC | 2,712,041 | $44.4B | 3.78% | |
| 10 | OPHTEURIVERIC BIO INC | 2,421,563 | $40.8B | 3.47% | |
| 11 | NVLSEURALPINE IMMUNE SCIENCES INC | 4,185,757 | $37.5B | 3.20% | |
| 12 | VRDNVIRIDIAN THERAPEUTICS INC | 1,739,530 | $32.2B | 2.74% | |
| 13 | CRNXCRINETICS PHARMACEUTICALS IN | 1,414,823 | $31.1B | 2.65% | |
| 14 | BCYCBICYCLE THERAPEUTICS PLC | 603,521 | $26.5B | 2.26% | |
| 15 | TARSTARSUS PHARMACEUTICALS INC | 1,417,157 | $23.8B | 2.03% | |
| 16 | KALVKALVISTA PHARMACEUTICALS INC | 1,572,192 | $23.2B | 1.97% | |
| 17 | ANABANAPTYSBIO INC | 899,700 | $22.3B | 1.90% | |
| 18 | 2JQGRITSTONE BIO INC | 5,237,348 | $21.6B | 1.84% | |
| 19 | COGTCOGENT BIOSCIENCES INC | 2,651,754 | $19.9B | 1.69% | |
| 20 | ARVNARVINAS INC | 270,331 | $18.2B | 1.55% | |
| 21 | 1T7TRICIDA INC | 2,082,093 | $17.1B | 1.46% | |
| 22 | SLNSILENCE THERAPEUTICS PLC | 881,173 | $16.7B | 1.43% | |
| 23 | MRUSMERUS N V | 628,979 | $16.6B | 1.42% | |
| 24 | AUTLAUTOLUS THERAPEUTICS PLC | 3,746,857 | $15.6B | 1.33% | |
| 25 | PASGPASSAGE BIO INC | 5,009,219 | $15.5B | 1.32% | |
| 26 | —PARDES BIOSCIENCES INC | 2,081,007 | $15.0B | 1.28% | |
| 27 | —FRAZIER LIFESCIENCES ACQU CO | 1,501,000 | $15.0B | 1.28% | |
| 28 | NTLAINTELLIA THERAPEUTICS INC | 203,684 | $14.8B | 1.26% | |
| 29 | STROSUTRO BIOPHARMA INC | 1,776,479 | $14.6B | 1.24% | |
| 30 | TYRATYRA BIOSCIENCES INC | 1,327,665 | $14.2B | 1.21% | |
| 31 | REPLREPLIMUNE GROUP INC | 716,762 | $12.2B | 1.04% | |
| 32 | GRCLGRACELL BIOTECHNOLOGIES INC | 3,445,973 | $8.0B | 0.68% | |
| 33 | ACRSACLARIS THERAPEUTICS INC | 408,329 | $7.0B | 0.60% | |
| 34 | AVDLAVADEL PHARMACEUTICALS PLC | 951,814 | $6.5B | 0.55% | |
| 35 | —MOLECULAR TEMPLATES INC | 1,374,047 | $4.7B | 0.40% | |
| 36 | EPIEURESSA PHARMA INC | 692,910 | $4.3B | 0.36% | |
| 37 | —APTINYX INC | 1,883,244 | $4.3B | 0.36% | |
| 38 | IMVTIMMUNOVANT INC | 585,759 | $3.2B | 0.28% | |
| 39 | SRRKSCHOLAR ROCK HLDG CORP | 156,000 | $2.0B | 0.17% | |
| 40 | CERE1EURCEREVEL THERAPEUTICS HLDNG I | 55,835 | $2.0B | 0.17% | |
| 41 | —EPIZYME INC | 739,369 | $850.0M | 0.07% | |
| 42 | —NABRIVA THERAPEUTICS PLC | 425,650 | $179.0M | 0.02% |